Clinical Trials

220 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06439225 2026-04-16

OPTION-DDR

236 enrolled

Prostatic Neoplasms

NCT07152821 2026-04-16

BATTMAN

834 enrolled

Phase NA Not yet recruiting

Colorectal Neoplasms

NCT07278739 2026-04-16

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

1,020 enrolled

Other solid neoplasm

Malignant Solid Neoplasm

NCT04195399 2026-04-15

A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery

31 enrolled

Sarcoma

Desmoid Tumors

NCT07107529 2026-04-15

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Phase NA Not yet recruiting

150 enrolled

Plasma cell

Multiple Myeloma

NCT07530679 2026-04-15

Study on the Safety, Humoral Immune Response, and Memory B Cell Response Characteristics of Sequential 9-Valent HPV Vaccination

360 enrolled

Cervical Cancer Prevention

NCT02821013 2026-04-14

STOP-GAP

614 enrolled

Dermatologic

Melanoma

NCT03488693 2026-04-14

TAILOR RT

2,140 enrolled

Breast Neoplasms

NCT03550391 2026-04-14

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

206 enrolled

CNS

Brain Neoplasms

NCT05077527 2026-04-14

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Phase 1 Recruiting

20 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, Large B-Cell, Diffuse

NCT05451004 2026-04-14

SELECT

510 enrolled

Head & Neck

Oropharyngeal Neoplasms

NCT05640999 2026-04-14

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

393 enrolled

Endometrial Neoplasms

NCT05998642 2026-04-14

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma

30 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT06182774 2026-04-14

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

570 enrolled

Plasma cell

Multiple Myeloma

NCT06205485 2026-04-14

NEO-RT

250 enrolled

Rectal Neoplasms

NCT06235697 2026-04-14

ASCENDE-SBRT

710 enrolled

Prostatic Neoplasms

NCT06592924 2026-04-14

TRIPLE-SWITCH

830 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT06641791 2026-04-14

Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer

196 enrolled

Head & Neck

Head and Neck Neoplasms

NCT06686771 2026-04-14

CURB2

320 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06880523 2026-04-14

SLIDE-HCC

140 enrolled

Carcinoma, Hepatocellular

NCT06931717 2026-04-14

ARCH

390 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00802711 2026-04-13

3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast Cancer

Phase NA Terminated

6 enrolled

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT01164150 2026-04-13

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

Phase 2 Terminated

92 enrolled

Radiation Injuries, Endometrial Neoplasms

NCT01244789 2026-04-13

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

244 enrolled

Endometrial Neoplasms

NCT01982786 2026-04-13

Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer

Phase NA Completed

57 enrolled 16 charts

Prostatic Neoplasms

NCT02151019 2026-04-13

TRI-LARC

Phase 1/2 Terminated

94 enrolled

Locally Advanced Rectal Cancer

NCT02225704 2026-04-13

Radium-223 in Combination With Enzalutamide

Phase 2 Completed

45 enrolled

Prostatic Neoplasms

NCT02630693 2026-04-13

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

Phase 2 Completed

180 enrolled 14 charts

Breast Neoplasms

NCT02705859 2026-04-13

Panther

Phase 1 Completed

26 enrolled

HER2 Positive Breast Cancer

NCT02764086 2026-04-13

INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung Cancer

Phase 1/2 Terminated

6 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03817398 2026-04-13

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Other hematologic neoplasm

110 enrolled

Leukemia, Myeloid, Chronic-Phase

NCT03869762 2026-04-13

DICE

Phase 2 Terminated

7 enrolled

Phase 3 Active not recruiting

Neoplasm Metastasis, Prostatic Neoplasms

NCT04650581 2026-04-13

FINER

250 enrolled 13 charts

Phase 1 Active not recruiting

Breast Neoplasms

NCT04667663 2026-04-13

CPD-DARA

16 enrolled

Plasma cell

Multiple Myeloma

NCT05518110 2026-04-13

PaTcH

Phase 2 Terminated

20 enrolled

Phase 1 Not yet recruiting

Pancreatic Neoplasms

NCT07297667 2026-04-13

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

30 enrolled

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT03259035 2026-04-09

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

Phase 2 Completed

58 enrolled 12 charts

Phase 3 Active not recruiting

Rectal Neoplasms

NCT03820830 2026-04-09

POLAR

405 enrolled

Phase 2 Enrolling by invitation

Breast Cancer Recurrent

NCT07062354 2026-04-09

CAPT-HN

50 enrolled

Head & Neck

Head and Neck Neoplasms

NCT01503632 2026-04-08

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Phase 3 Completed

570 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02595424 2026-04-08

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

67 enrolled 13 charts

Endocrine

Somatostatinoma, Carcinoma, Neuroendocrine

NCT03067181 2026-04-07

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Phase NA Active not recruiting

1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT04496739 2026-04-07

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

412 enrolled

Phase NA Active not recruiting

Breast Carcinoma In Situ

NCT03033992 2026-04-06

Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG

80 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma

NCT04903080 2026-04-06

HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma

Phase 1 Active not recruiting

50 enrolled

Ependymoma

NCT04978727 2026-04-06

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Phase 1 Active not recruiting

35 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Ependymoma, Glioblastoma, Medulloblastoma, Oligodendroglioma

NCT03115333 2026-04-03

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Phase NA Active not recruiting

146 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT03516279 2026-04-03

Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease